PCSK9 and carbohydrate metabolism: A double-edged sword

Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a paramount role in the degradation of low-density lipoprotein (LDL) receptors (LDLR) on the hepatic cells surface and subsequently affects LDL particles catabolism and LDL cholesterol (LDL-c) levels. The anti-PCSK9 monoclonal antibodies le...

全面介紹

Na minha lista:
書目詳細資料
發表在:World J Diabetes
Main Authors: Filippatos, Theodosios D, Filippas-Ntekouan, Sebastian, Pappa, Eleni, Panagiotopoulou, Thalia, Tsimihodimos, Vasilios, Elisaf, Moses S
格式: Artigo
語言:Inglês
出版: Baishideng Publishing Group Inc 2017
主題:
Editorial
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5507827/
https://ncbi.nlm.nih.gov/pubmed/28751953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4239/wjd.v8.i7.311
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍